vimarsana.com

Page 49 - பணியகம் ஆஃப் நுகர்வோர் ப்ரொடெக்ஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FTC enforcement action targets six CBD firms over unsubstantiated claims

FTC enforcement action targets six CBD firms over unsubstantiated claims The Federal Trade Commission unveiled an enforcement action today against six sellers of CBD products that it alleges have been making unsubstantiated disease treatment claims. FTC has levied more than $246,000 in fines in the cases. The action was announced on the agency’s website this morning.  According to the statement, the CBD firms (two firms also market CBG products) were allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others. The six companies will be required to stop making the claims immediately. Fines were levied in all but one of the cases.  The fines ranged from $20,000 to $85,000.  In addition to the fines the defendants are prohibited in the future from making health benefit claims without competent and reliable sc

FTC Announces Crackdown on Deceptively Marketed CBD Products

Andrew Smith, Director, Bureau of Consumer Protection on Thursday, December 17, 2020.   The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The FTC is taking action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others. The FTC is requiring each of the companies, and individuals behind them, to stop making such unsupported health claims immediately, and several will pay monetary judgments to the agency. The orders settling the FTC’s complaints also bar the respondents from similar deceptive advertising in the future, and require that they have scientific evidence to support any health claims they make for CBD and other products.

U S officials warn of escalating COVID-19 vaccine scams - World News

2020-12-17 11:05:30 GMT2020-12-17 19:05:30(Beijing Time) Xinhua English by Julia Pierrepont III LOS ANGELES, Dec. 16 (Xinhua) As Californians - in fact, all Americans - wait anxiously for the arrival of the life-saving COVID-19 vaccine, another sinister threat has reared its ugly head: vaccine scam. Some unscrupulous crooks used the newly approved vaccine as a way of coaxing money by concocting fake vaccines and peddling them to impatient consumers living in fear for their lives, officials warned, adding other hoaxers use the topic of vaccine to steal personal information out of victims. The vaccine won t be available on a widespread basis until spring or early summer. In the meantime, that means there will be a wait, and that wait is surely an opportunity for scammers to try to sell you fake vaccines that are ineffective at best and dangerous at worst, Los Angeles City Attorney Mike Feuer said in a public announcement posted on Wednesday.

Ascension Settles With FTC Over Mortgage Data Mishap

Have suggestions for products that you’d like to see reviewed by our real estate technology expert? Email Craig Rowe. Allegations by the Federal Trade Commission (FTC) against Texas-based Ascension Data & Analytics, LLC has resulted in the mortgage data analytics company’s requirement to install an enterprise-wide data security program, according to a press release issued by the FTC. The case is the result of the commission’s discovery that a vendor of Ascension was not sufficiently protecting personal information for mortgage holders. Under the Gramm-Leach-Bliley Act’s Safeguards Rule, financial institutions are accountable for the actions of vendors, data security being critical to that oversight.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.